| Financial Year |
March 31 2023 |
| Monetary Funds |
3,262,648,298.88 |
| Held-for-trading Financial Assets |
190,738,981.69 |
| Notes Receivable |
563,882,313.23 |
| Accounts Receivable |
439,340,414.32 |
| Advances to Suppliers |
57,767,638.42 |
| Other Receivables |
42,319,976.31 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
839,637,821.41 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
740,851,689.31 |
| Total Current Assets |
6,276,333,528.12 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
5,400,000.00 |
| Long-term Equity Investment |
73,898,524.16 |
| Investment Properties |
33,276,935.01 |
| Fixed Assetes |
2,790,447,968.95 |
| Under-construction Projects |
1,790,627,252.59 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
369,393,648.68 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
11,897,779.64 |
| Deferred Income Tax Assets |
18,818,945.53 |
| Other Non-Current Assets |
857,152,069.86 |
| Sub-Total of Non-Current Assets |
6,613,863,529.71 |
| Total Assets |
12,890,197,057.83 |
| Short-Term Loans |
878,485,646.79 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,012,518,033.13 |
| Accounts Payable |
921,514,760.67 |
| Accounts Received In Advance |
11,000,000.00 |
| Employee Compensation Payable |
44,645,728.60 |
| Taxes Payable |
51,690,175.82 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
188,842,068.41 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
317,643,641.10 |
| Other Current Liabilities |
269,015,429.99 |
| Sub-Total of Current Liabilities |
3,740,136,285.68 |
| Long-term Loans |
1,203,600,334.24 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
90,342,466.39 |
| Other Non-Current Liabilities |
834,161.69 |
| Sub-Total of Non-Current Liabilities |
1,403,654,266.13 |
| Total Liabilities |
5,143,790,551.81 |
| Paid-In Capital(Or Share Stock) |
862,934,983.00 |
| Capital Surplus |
3,880,608,255.69 |
| Surplus Reserve |
434,740,372.27 |
| LESS:Treasury Stock |
173,992,500.00 |
| Undistributed Profits |
2,187,232,795.91 |
| Minority Stockholder's Interest |
547,992,359.18 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,198,414,146.84 |
| Owner's Equity（Stockholder's Equity） |
7,746,406,506.02 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
12,890,197,057.83 |
